These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7940348)

  • 1. [The efficacy of diclonate P in psoriatic arthritis].
    Burdeĭnyĭ AP
    Ter Arkh; 1994; 66(5):75-7. PubMed ID: 7940348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diclonate P in rheumatoid arthritis].
    Tsvetkova ES; Alekberova ZS; Balabanova RM; Ivanova MM; Chichasova NV; Nasonov EL
    Ter Arkh; 1994; 66(5):69-72. PubMed ID: 7940345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Voltaren gel in the combined treatment of patients with psoriatic arthritis].
    Shakhtmeĭster IIa; Kamennykh EV
    Vestn Dermatol Venerol; 1990; (10):55-7. PubMed ID: 2278198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of diclonate P on the clinical course of rheumatoid arthritis].
    Dormidontov EN; Korshunov NI; Baranova EIa; Parusova NI; Ial'tseva NV; Savel'eva MI
    Ter Arkh; 1994; 66(5):73-4. PubMed ID: 7940347
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.
    Pareek A; Chandanwale AS; Oak J; Jain UK; Kapoor S
    Curr Med Res Opin; 2006 May; 22(5):977-88. PubMed ID: 16709320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis.
    Morgan C; Lunt M; Bunn D; Scott DG; Symmons DP
    Rheumatology (Oxford); 2007 Dec; 46(12):1819-23. PubMed ID: 18032539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices.
    Gottlieb AB; Mease PJ; Mark Jackson J; Eisen D; Amy Xia H; Asare C; Stevens SR
    J Dermatolog Treat; 2006; 17(5):279-87. PubMed ID: 17092858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of severe psoriatic arthritis with methotrexate in a weekly "mini-pulse" dosage plan].
    Parasca I; Boloşiu HD; Rus V; Duţu A
    Med Interna; 1991; 43(1-2):150-3. PubMed ID: 1670121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained clinical response and high infliximab survival in psoriatic arthritis patients: a 3-year long-term study.
    Voulgari PV; Venetsanopoulou AI; Exarchou SA; Alamanos Y; Tsifetaki N; Drosos AA
    Semin Arthritis Rheum; 2008 Apr; 37(5):293-8. PubMed ID: 17888499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent inhibition of diclofenac sodium on posterior lumbar interbody fusion rates.
    Lumawig JM; Yamazaki A; Watanabe K
    Spine J; 2009 May; 9(5):343-9. PubMed ID: 18790686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.
    Kidd B; Frenzel W
    J Rheumatol; 1996 Sep; 23(9):1605-11. PubMed ID: 8877932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
    Kivitz AJ; Espinoza LR; Sherrer YR; Liu-Dumaw M; West CR
    Semin Arthritis Rheum; 2007 Dec; 37(3):164-73. PubMed ID: 17570469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE; Gülfe A; Saxne T; Geborek P
    Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with cyclosporin in patients with psoriatic arthritis: results of clinical assessment.
    Raffayová H; Rovenský J; Mális F
    Int J Clin Pharmacol Res; 2000; 20(1-2):1-11. PubMed ID: 11146896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of infliximab in resistant psoriatic arthritis.
    Salvarani C; Cantini F; Olivieri I; Macchioni P; Padula A; Niccoli L; Catanoso MG; Scocco GL; Boiardi L
    Arthritis Rheum; 2003 Aug; 49(4):541-5. PubMed ID: 12910561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate in psoriatic polyarthritis.
    Pigatto PD; Gibelli E; Ranza R; Rossetti A
    Acta Derm Venereol Suppl (Stockh); 1994; 186():114-5. PubMed ID: 8073807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of psoriatic arthritis in a population of patients with psoriasis].
    Jajić Z; el Assadi G
    Acta Med Croatica; 2003; 57(4):323-6. PubMed ID: 14639870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
    de Vlam K; Lories RJ
    Rheumatology (Oxford); 2006 Mar; 45(3):321-4. PubMed ID: 16234275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.